NewGenIvf has $2.04M in outstanding convertible notes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NewGenIvf Group Ltd (NIVF) reported its share counts and outstanding convertible notes as of November 17, 2026. It had 2,790,883 Class A ordinary shares outstanding, including 2,752,036 held by non-affiliates, and 9,136 Class B ordinary shares outstanding.
The company reported convertible notes with an aggregate principal amount of US$2,044,373; US$323,812, representing notes outstanding more than 180 days, was currently eligible for conversion. The remaining notes were subject to escrow or Rule 144 restrictions and were not freely convertible at that time.
Key Figures
Key Terms
convertible notes financial
aggregate principal amount financial
Rule 144 restrictions regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of NewGenIvf’s (NIVF) convertible notes was eligible for conversion?
AI-generated analysis. How Rhea-AI works. Not financial advice.